← Find more feeds

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 170 followers

Latest posts

Last updated about 3 hours ago

CHMP work plan 2022

about 3 hours ago

Read full

Human medicines European public assessment report (EPAR): Ranexa (previously Latixa), ranolazine, Angina Pectoris, Date of authorisation: 08/07/2008, Revision: 22, Status: Authorised

about 7 hours ago

Read full

EMA business hours over Assumption Day, 15 August

about 9 hours ago

Read full

https://www.ema.europa.eu/en/medicines/dhpc/hiprabovis-ibr-marker-live-infectious-bovine-rhinotracheitis-vaccine-live-increase-incidence

about 9 hours ago

Read full

Direct animal healthcare professional communications

about 9 hours ago

Read full

Orphan designation: allogeneic peripheral blood mononuclear cells incubated ex-vivo with 16, 16-dimethyl prostaglandin E2,dexamethasone, Treatment in haematopoietic stem cell transplantation, 10/08/2022, Withdrawn

1 day ago

Read full

Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Neutropenia, Date of authorisation: 20/06/2019, Revision: 3, Status: Authorised

1 day ago

Read full

Human medicines European public assessment report (EPAR): Vaxelis, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed), Meningitis, Haemophilus;Poliomye

1 day ago

Read full

Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Myocardial Infarction, Date of authorisation: 23/02/2001, Revision: 20, Status: Authorised

1 day ago

Read full

Human medicines European public assessment report (EPAR): Gliolan, 5-aminolevulinic acid hydrochloride, Glioma, Date of authorisation: 07/09/2007, Revision: 7, Status: Authorised

1 day ago

Read full

Decision of the Executive Director on rules governing the traineeship programme at the EMA

1 day ago

Read full

Cetrotide (cetrorelix acetate) supply shortage

1 day ago

Read full

Or log in

Everything you care about in one place

What's new

Latest posts

CHMP work plan 2022

Human medicines European public assessment report (EPAR): Ranexa (previously Latixa), ranolazine, Angina Pectoris, Date of authorisation: 08/07/2008, Revision: 22, Status: Authorised

EMA business hours over Assumption Day, 15 August

https://www.ema.europa.eu/en/medicines/dhpc/hiprabovis-ibr-marker-live-infectious-bovine-rhinotracheitis-vaccine-live-increase-incidence

Direct animal healthcare professional communications

Orphan designation: allogeneic peripheral blood mononuclear cells incubated ex-vivo with 16, 16-dimethyl prostaglandin E2,dexamethasone, Treatment in haematopoietic stem cell transplantation, 10/08/2022, Withdrawn

Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Neutropenia, Date of authorisation: 20/06/2019, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Vaxelis, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed), Meningitis, Haemophilus;Poliomye

Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Myocardial Infarction, Date of authorisation: 23/02/2001, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Gliolan, 5-aminolevulinic acid hydrochloride, Glioma, Date of authorisation: 07/09/2007, Revision: 7, Status: Authorised

Decision of the Executive Director on rules governing the traineeship programme at the EMA

Cetrotide (cetrorelix acetate) supply shortage

Try Feeder for free